Clinical Trial

NODE (groiN ultrasOunD cancEr)

Study acronym: NODE
Recruiting
View on ClinicalTrials.gov →
Summary
This study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to randomise vulvar cancer patients into one of two treatment arms:1) surgical groin node dissection (as delivered though either a sentinel node biopsy or inguinofemoral lymph node dissection (IFL), or 2) serial high-resolution bilateral groin ultrasound surveillance and clinical examination every 2 months for 12 months.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-02-08; most recent amendment 2026-02-18.
Status change: Not Yet Recruiting → Recruiting 2024-12-02
Trial Details
NCT Number NCT06264167
Lead Sponsor Queensland Centre for Gynaecological Cancer
Collaborators: Royal Brisbane and Women's Hospital, St Andrew's War Memorial Hospital, Buderim Private Hospital
Conditions Vulvar Cancer Stage Ib, Vulvar Cancer Stage II, Lymph Node Metastasis, Groin Node, Ultrasound Therapy; Complications
Enrollment 30 participants
Start Date 2024-07-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-20